The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Taractan     3-(2-chlorothioxanthen-9- ylidene)-N,N...

Synonyms: Iaractan, Rentovet, Tactaran, Vetacalm, Traquilan, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Taractan


Psychiatry related information on Taractan


High impact information on Taractan


Chemical compound and disease context of Taractan


Biological context of Taractan


Anatomical context of Taractan


Associations of Taractan with other chemical compounds


Gene context of Taractan


Analytical, diagnostic and therapeutic context of Taractan


  1. Neurolepticlike actions of l-methadone: effect on mescaline-induced altered behavior and on tissue levels of mescaline in mice. Shah, N.S., Hudnall, S.D., May, D., Eargle, D., Yates, J. Biol. Psychiatry (1979) [Pubmed]
  2. Chlorprothixene (taractan) in post-herpetic neuralgia and other severe chronic pains. Nathan, P.W. Pain (1978) [Pubmed]
  3. Polyneuropathy caused by chlorprothixene. Luisto, M. Acta psychiatrica Scandinavica. (1992) [Pubmed]
  4. Contact dermatitis to chlorprothixene. Lepp, U., Schlaak, M., Schulz, K.H. Allergy (1998) [Pubmed]
  5. Acute oliguria associated with chlorprothixene overdosage. Scheithauer, W., Ulrich, W., Kovarik, J., Stummvoll, H.K. Nephron (1988) [Pubmed]
  6. Bromazepam in generalized anxiety. Randomized, multi-practice comparisons with both chlorprothixene and placebo. Kragh-Sørensen, P., Holm, P., Fynboe, C., Schaumburg, E., Andersen, B., Bech, P., Pichard, J. Psychopharmacology (Berl.) (1990) [Pubmed]
  7. Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics--a study comparing adjuvant treatment with oxazolam versus chlorprothixene. Laux, G., Koenig, W., Pfaff, G. Pharmacopsychiatry (1988) [Pubmed]
  8. Separation of (Z)- and (E)-isomers of thioxanthene and dibenz[b,e]oxepin derivatives with calixarenes and resorcinarenes as additives in nonaqueous capillary electrophoresis. Sokoliess, T., Gronau, M., Menyes, U., Roth, U., Jira, T. Electrophoresis (2003) [Pubmed]
  9. Chlorprothixene-induced systemic lupus erythematosus. McNevin, S., MacKay, M. Journal of clinical psychopharmacology. (1982) [Pubmed]
  10. Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration. Bagli, M., Süverkrüp, R., Quadflieg, R., Höflich, G., Kasper, S., Möller, H.J., Langer, M., Barlage, U., Rao, M.L. J. Pharmacol. Exp. Ther. (1999) [Pubmed]
  11. Efficacy of novel antimicrobials against clinical isolates of opportunistic amebas. Schuster, F.L., Visvesvara, G.S. J. Eukaryot. Microbiol. (1998) [Pubmed]
  12. Trimipramine and other antipsychotics inhibit Campylobacter pylori in vitro. Kristiansen, J.E., Justesen, T., Hvidberg, E.F., Andersen, L.P. Pharmacol. Toxicol. (1989) [Pubmed]
  13. Elimination of F'lac plasmid by different psychotropic drugs and some related compounds. Farkas, S., Molnár, J. Acta microbiologica Academiae Scientiarum Hungaricae. (1979) [Pubmed]
  14. Gamma-hydroxybutyrate versus chlorprothixene/phenobarbital sedation in children undergoing MRI studies. Meyer, S., Gottschling, S., Georg, T., Lothschütz, D., Graf, N., Sitzmann, F.C. Klinische Pädiatrie. (2003) [Pubmed]
  15. Penfluridol, chlorprothixene and haloperidol block fast axonal transport in an order of potency consistent with a mechanism related to inhibition of calmodulin. Lavoie, P.A. Neuropharmacology (1987) [Pubmed]
  16. Tricyclic drugs reduce proton motive force in Leishmania donovani promastigotes. Zilberstein, D., Liveanu, V., Gepstein, A. Biochem. Pharmacol. (1990) [Pubmed]
  17. Mean input times of three oral chlorprothixene formulations assessed by an enhanced least-squares deconvolution method. Bagli, M., Süverkrüp, R., Rao, M.L., Bode, H. Journal of pharmaceutical sciences. (1996) [Pubmed]
  18. On the pharmacokinetics of chlorprothixene in man. Raaflaub, J. Experientia (1975) [Pubmed]
  19. Relation of albinism and drugs to the visual evoked potential of the mouse. Henry, K.R., Rhoades, R.W. Journal of comparative and physiological psychology. (1978) [Pubmed]
  20. Phenolic metabolites of chlorprothixene in man and dog. Breyer-Pfaff, U., Wiest, E., Prox, A., Wachsmuth, H., Protiva, M., Sindelár, K., Friebolin, H., Krauss, D., Kunzelmann, P. Drug Metab. Dispos. (1985) [Pubmed]
  21. Presence of chlorprothixene and its metabolites in breast milk. Matheson, I., Evang, A., Overø, K.F., Syversen, G. Eur. J. Clin. Pharmacol. (1984) [Pubmed]
  22. Chlorprothixene and chlorprothixene-sulfoxide in body fluids from a case of drug overdose. Poklis, A., Maginn, D., Mackell, M.A. Journal of analytical toxicology. (1983) [Pubmed]
  23. The effect of neuroleptics on imipramine demethylation in rat liver microsomes and imipramine and desipramine level in the rat brain. Daniel, W., Melzacka, M. Biochem. Pharmacol. (1986) [Pubmed]
  24. Determination of chlorprothixene and its sulfoxide metabolite in plasma by high-performance liquid chromatography with ultraviolet and amperometric detection. Brooks, M.A., DiDonato, G., Blumenthal, H.P. J. Chromatogr. (1985) [Pubmed]
  25. Simultaneous LC determination of some antidepressants combined with neuroleptics. Karpinska, J., Starczewska, B. Journal of pharmaceutical and biomedical analysis. (2002) [Pubmed]
  26. Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations. Bagli, M., Rao, M.L., Höflich, G., Kasper, S., Langer, M., Barlage, U., Beneke, M., Süverkrüp, R., Möller, H.J. Arzneimittel-Forschung. (1996) [Pubmed]
  27. Hemoperfusion in severe chlorprothixene overdose. Köppel, C., Schirop, T., Ibe, K., Tenczer, J., Ehrenburg, J., Gayer, J. Intensive care medicine. (1987) [Pubmed]
  28. ELISA screening with GC-MS confirmation of the tranquilizer chlorprothixene administered in subtherapeutic doses to horses. Delbeke, F.T., Teale, P., Debackere, M., Houghton, E. Journal of pharmaceutical and biomedical analysis. (1993) [Pubmed]
  29. A controlled comparative study of chlorprothixene vs. haloperidol in chronic schizophrenia. Fux, M., Belmaker, R.H. The Israel journal of psychiatry and related sciences. (1991) [Pubmed]
WikiGenes - Universities